In 2008, 25 percent of all drugs approved by the U.S. Food andDrug Administration were considered specialty drugs—what the FDAcalls new molecular entities—and that number only has gone upsince. Now, more than 50 percent of all drugs approved by the FDAare specialty drugs.

And, according to Reuters, the top 3selling pharmaceuticals in 2014 will be specialty or oncologydrugs, topping mainstays such as Lipitor, Plavix andAdvair.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.